← Back to Search

Waitlist for Agoraphobia

N/A
Waitlist Available
Led By Elizabeth A Hoge
Research Sponsored by Georgetown University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 16 weeks
Awards & highlights

Study Summary

This study will evaluate the effects of Mindfulness-Based Stress Reduction (MBSR) on physiological reactivity. This study will focus on individuals with anxiety who will participate in an 8-week MBSR class. The investigators will test participants' reactivity to both predictable and unpredictable stimuli before and after the class to understand the physiological changes that may occur after to the intervention. Secondary measures include psychometric instruments and a delay discounting task.

Eligible Conditions
  • Agoraphobia
  • Generalized Anxiety Disorder
  • Social Anxiety Disorder
  • Post-Traumatic Stress Disorder
  • Simple Phobia
  • Panic Disorder
  • Anxiety Disorders

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~16 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 16 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Fear and anxiety potentiated startle
Secondary outcome measures
Center for Epidemiologic Studies Depression Scale (CES-D)
Delay Discounting
The State-Trait Anxiety Inventory (STAI)

Trial Design

2Treatment groups
Experimental Treatment
Group I: WaitlistExperimental Treatment1 Intervention
The wait-list group will not participate in the MBSR course within 4 weeks of their first testing visit. They will wait 8-16 weeks and come on for a second testing visit. After their data is collected they will be offered an MBSR course to take.
Group II: Mindfulness-Based Stress ReductionExperimental Treatment1 Intervention
This group will take the 8 week MBSR course within 4 weeks of their first testing visit. When the course is finished they will come in for their second testing visit. The course meets once a week in person for 2.5 hours and participants are expected to do practices at home.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mindfulness-Based Stress Reduction
2015
Completed Phase 4
~1880
Waitlist
2010
Completed Phase 4
~2850

Find a Location

Who is running the clinical trial?

Georgetown UniversityLead Sponsor
343 Previous Clinical Trials
136,457 Total Patients Enrolled
2 Trials studying Agoraphobia
316 Patients Enrolled for Agoraphobia
Elizabeth A HogePrincipal InvestigatorGeorgetown University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Effect of Mindfulness Meditation on Physiological Response to Unpredictable Stimuli
2017. "Effect of Mindfulness Meditation on Physiological Response to Unpredictable Stimuli". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03206437.
~6 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top